Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Actual shortage 17.5MG Updated Report 2022-11-27 175814
ACH-ATORVASTATIN CALCIUM ACCORD HEALTHCARE INC Actual shortage 80MG Updated Report 2022-11-27 175819
ACH-METHOTREXATE ACCORD HEALTHCARE INC Actual shortage 2.5MG Updated Report 2022-11-27 175835
ACH-APIXABAN ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2022-11-27 175838
APO-OLANZAPINE APOTEX INC Actual shortage 10MG Updated Report 2022-11-26 171422
TRI-CIRA LO 21 APOTEX INC Actual shortage 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG Updated Report 2022-11-26 172942
APO-METHYLPHENIDATE ER APOTEX INC Actual shortage 27MG Updated Report 2022-11-26 173831
APO-METHYLPHENIDATE ER APOTEX INC Actual shortage 18MG Updated Report 2022-11-26 159703
APO-DASATINIB APOTEX INC Actual shortage 50MG Updated Report 2022-11-26 172360
APO-NAPROXEN APOTEX INC Resolved 500MG Updated Report 2022-11-26 169513

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165397
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165462
HIBERIX GLAXOSMITHKLINE INC To be discontinued 10MCG New Report 2022-11-18 175258
!!T3 INTEGRILIN MERCK CANADA INC Discontinued 0.75MG Updated Report 2022-11-18 155790
!!T3 INTEGRILIN MERCK CANADA INC Discontinued 2MG Updated Report 2022-11-18 155794